01

Douglas Pharmaceuticals Ltd.

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

Contact Supplier

New Zealand

Virtual Booth

Digital Content

Regulatory Info : Generic

Registration Country : New Zealand

Cyproterone Acetate; Ethinyl Estradiol

Brand Name :

Dosage Form : TABLET

Dosage Strength : 35MCG; 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : New Zealand

Portfolio PDF

Corporate PDF

02

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Desogestrel; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.15MG; 0.03MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

03

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Desogestrel; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.15MG; 0.02MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

04

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Drospirenone; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 3MG; 0.03MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

05

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Levonorgestrel; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.15MG; 0.03MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

06

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Levonorgestrel; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.10MG; 0.02MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

07

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Norgestimate; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.180MG; 0.035MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

08

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Norgestimate; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.215MG; 0.035MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

09

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Norgestimate; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.25MG; 0.035MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

10

Strides Pharma Science

India

euroPLX 88 Lisbon

Attending

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : India

Norethisterone; Ethinyl Estradiol

Brand Name :

Dosage Form : Tablet

Dosage Strength : 1MG; 0.035MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

LOESTRIN 21 1.5/30

LOESTRIN 21 1.5/30

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers

14 USDMF

10 CEP/COS

4 JDMF

3 EU WC

14 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

729 FDF Dossiers

418 FDA Orange Book

107 Europe

88 Canada

56 South Africa

60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG

TABLET;ORAL-21 - 0.03MG;1.5MG

TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-21 - 0.03MG;1.5MG

TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A

CAPSULE;ORAL - 0.02MG;1MG

TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A

TABLET;ORAL - 0.02MG;0.1MG

RING;VAGINAL - 0.013MG/24HR;0.15MG/24HR

TABLET;ORAL - 0.0025MG;0.5MG

TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.035MG/24HR;0.15MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RING;VAGINAL - 0.015MG/24HR;0.12MG/24HR

TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 3MG;0.02MG

TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

5 SPI Pharma

6 DKSH

7 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

5 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

25 BASF

2 Clariant

11 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

1 Finar

8 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

38 Kerry

TABLET;ORAL-28 - 0.03MG;0.3MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-21 - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG;0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-21 - 0.15MG;0.03MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.005MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.035MG/24HR;0.15MG/24HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.035MG;0.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons